Global Information
회사소개 | 문의 | 비교리스트

중국의 유방암 치료제 시장

Breast Cancer Treatment Drug Markets in China

리서치사 Asia Market Information & Development Co.
발행일 2022년 06월 상품코드 81745
페이지 정보 영문 256 Pages 배송안내
가격
US $ 4,000 ₩ 5,254,000 PDF (Single User License)
US $ 8,000 ₩ 10,508,000 PDF (Corporate User License)


중국의 유방암 치료제 시장 Breast Cancer Treatment Drug Markets in China
발행일 : 2022년 06월 페이지 정보 : 영문 256 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

중국의 유방암(Breast Cancer) 치료제 수요는 지난 10년간 빠른 속도로 증가했습니다. 향후 5년간도 생산, 수요 모두 꾸준한 증가세를 보일 전망입니다.

중국의 경제 동향, 투자 환경, 산업의 발전, 수요 및 공급, 산업 구조, 시장 채널 및 주요 기업 등에 대해 상세하게 조사하고, 과거 실적과 장기 예측 등을 전해드립니다.

제1장 서론

  • 본 보고서의 범위 및 조사 방법
  • 개요

제2장 비지니스 환경

  • 경제 전망
    • 주요 경제지표
    • 공업 생산량
    • 인구 및 노동력
    • 해외로부터의 투자
    • 해외 무역
  • 금융 및 세금 규제
    • 은행 제도 및 규제
    • 외환
    • 세금, 관세 및 세관

제3장 유방암 치료제 산업 평가

  • 산업 구조
  • 시장 규모
  • 시장 성장 촉진요인
  • 판매량
  • 주요 제조업체의 설비 거점
  • 주요 제조업체의 판매량 및 시장 점유율
  • 노동 비용
  • 잠재성 있는 시장 진출기업
  • 주요 유통업체
  • 해외로부터의 주요 투자
  • 기술 개발

제4장 유방암 치료제 생산 및 수요

  • 개요
  • 판매량
    • 화학요법제
    • 파클리탁셀(Paclitaxel)
    • 플루오로피리미딘(Fluoropyrimidines )
    • 안트라사이클린 항생제(Anthracycline Antibiotics)
    • 표적 치료제
    • 치료 항체
    • 소분자 의약품
    • 아로마타제 억제제(표적 치료제)
    • 내분비선 치료제
    • 항에스트로겐(Anti-estrogens)
    • 프로게스테론(Progesterone )
    • 아로마타제 억제제(내분비선 치료제)
    • LH-RH
  • 수입
    • 화학요법제
    • 파클리탁셀
    • 플루오로피리미딘
    • 안트라사이클린 항생제
    • 표적 치료제
    • 치료 항체
    • 소분자 의약품
    • 아로마타제 억제제(표적 치료제)
    • 내분비선 치료제
    • 항에스트로겐
    • 프로게스테론
    • 아로마타제 억제제(내분비선 치료제)
    • LH-RH
  • 가격 동향

제5장 유방암 치료제 시장 전망

  • 유방암 치료제 시장 전망
  • 정부의 규제
  • 건강보험 산업 개요
  • 소비자 지출 동향
  • 인구 동태
  • 헬스케어 산업 동향
  • 병원 및 침상
  • 의사 및 왕진

제6장 마케팅 전략

  • 중국 시장 진출 개요
    • 중국의 유통 시스템
    • 유통 채널
    • 교통 및 운송 인프라
    • 통신
  • 중국 시장 진출
    • 라이선싱
    • 프랜차이즈
    • E-Commerce
    • 무역회사와 현지 대리점
    • 대표사무소와 중국 자회사
    • 100% 외자 기업

제7장 유방암 치료제 제조업체 디렉토리

  • 제조업체 개요 및 디렉토리
  • 주요 최종사용자

도표 리스트

LSH 12.08.24

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
  • Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Total Breast Cancer Treatment Drugs Sales Volume
  • Breast Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Progesterone Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Breast Cancer Treatment Drug Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2011, 2016 and 2021) and long-term forecasts through 2026 and 2031 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Industry Structure
  • Market Size
  • Market Growth Driver
  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Overview
  • Breast Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Breast Cancer Treatment Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Breast Cancer Treatment Drug Producer Profiles and Directory
Back to Top
전화 문의
F A Q